GBT-Grupo Biotoscana is a biopharmaceutical group that operates in LATAM region and focuses on infectious diseases, oncology, hematology, special treatments, immunology and rare diseases, among others. GBT operates under its companies Biotoscana, United Medical, LKM and DOSA. GBT’s portfolio combines world-class licenses from companies like Celgene, Gilead, Basilea Pharmaceutica, Eisai, Pierre Fabre; along with proprietary products. To find out more, please visit www.grupobiotoscana.com